SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 80.91 |
| Enterprise Value ($M) | 34.46 |
| Book Value ($M) | -90.54 |
| Book Value / Share | -15.96 |
| Price / Book | -0.89 |
| NCAV ($M) | -141.39 |
| NCAV / Share | -24.92 |
| Price / NCAV | -0.57 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.71 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.50 |
| Current Ratio | 0.59 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 91.86 |
| Assets | 142.71 |
| Liabilities | 233.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citadel Advisors Llc | 4.60 | ||
| 13G/A | EcoR1 Capital, LLC | 9.99 | -95.10 | |
| 13G/A | Vanguard Group Inc | 3.18 | 0.00 | |
| 13G/A | Redmile Group, LLC | 9.90 | -94.37 | |
| 13D/A | Adiumentum Capital Fund I LP | 19.99 | -85.94 | |
| 13G/A | BlackRock Inc. | 0.00 | -100.00 | |
| 13G/A | Maverick Capital Ltd | 0.00 | -100.00 | |
| 13G/A | Wasatch Advisors Inc | |||
| 13G/A | Goldman Sachs Group Inc | 0.60 | -90.49 | |
| 13G/A | State Street Corp | 2.73 | -63.60 | |
| 13G/A | Baupost Group Llc/ma | 0.00 | -100.00 | |
| 13G/A | Jpmorgan Chase & Co | 2.10 | -70.62 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,237 | 122,216 | 13.29 | |
| 62,228 | 298,070 | 20.88 | |
| 22,744 | 105,772 | 21.50 | |
| 32,033 | 186,775 | 17.15 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARWR – Arrowhead Pharmaceuticals, Inc. | ASMB – Assembly Biosciences, Inc. |
| ATHA – Athira Pharma, Inc. | AVIR – Atea Pharmaceuticals, Inc. |
| AVXL – Anavex Life Sciences Corp. |
Financial data and stock pages provided by
Fintel.io